Introduction: alterations in the circulating level of tumour necrosis factor-α (TNF-α) has been proposed to be involved in the pathogenesis of
Introduction
Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy [1] . The prevalence of gestational diabetes mellitus has been increasing dramatically worldwide over the last two decades [2] . In Nigeria the prevalence ranges from 3.4-13.9% across the different regions of the country [3] [4] [5] [6] [7] . Gestational diabetes mellitus is associated with increased obstetric and perinatal morbidity and mortality [2] . Despite remarkable progress made in the field of endocrinology, the exact mechanism implicated in the pathogenesis of gestational diabetes mellitus is still not completely understood.
Recently the role of inflammatory cytokines especially TNF-α has been increasingly investigated but findings are inconsistent especially across different ethnic groups [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . While ethnicity is one of the factors that influence production of cytokines during pregnancy [18] , studies on the association between alterations in the maternal circulating level of TNF-α and development of gestational diabetes mellitus among black African women are limited. We are not aware of any study done in Nigeria among women with gestational diabetes mellitus. This study was therefore designed to compare maternal circulating TNF-α levels between Nigerian pregnant women with and without gestational diabetes mellitus. Statistical analysis: statistical analysis was performed using the SPSS version 20.0 statistical package. Data are summarised using measures of central tendency and dispersion. We compared mean differences of serum TNF-α level between groups using t-test. All pvalues were 2-sided and considered significant if less than 0.05.
Methods

Results
Demographic characteristics of the study subjects are presented in Table 1 . Both the study groups were of similar maternal age, Table 2 . Serum level of TNF-α was significantly higher among the pregnant women with gestational diabetes mellitus compared to the controls (2.50 ± 0.30 vs. 2.10 ± 0.30 pg/ml, p < 0.05). When the maternal serum TNF-α levels of the pregnant women with gestational diabetes mellitus and the controls were compared for each level of BMI (Table 3) , serum TNF-α levels remained significantly higher in both the normal weight and overweight pregnant women with gestational diabetes mellitus compared to their matched controls (2.4 ± 0.3 vs. 1.9 ± 0.2 pg/ml, p < 0.05) and (2.6 ± 0.3 vs. 2.3 ± 0.2 pg/ml, p < 0.05) respectively (Figure 1 ).
Discussion
This study has shown that the pregnant women with gestational diabetes mellitus have higher serum TNF-α levels than the pregnant women with normal gestation. This finding of increased serum TNF-α level in pregnant women with gestational diabetes mellitus has been reported in many previous studies [8, [11] [12] [13] . Also in line with the results of this study Laetitia et al. reported that higher maternal serum level of TNF-α is a significant predictor of developing gestational diabetes mellitus [3] . When comparing maternal serum TNF-α levels of the study subjects for each level of body mass index, serum TNF-α levels remained significantly higher in both the normal weight and overweight pregnant women with gestational diabetes mellitus compared to their matched controls. The same finding was reported by McLachlan et al. [9] , although in a study with a relatively smaller sample size (19 GDM and 19 controls). However, the findings of Saucedo et al. did not show significant difference between serum TNF-α levels in pregnant women with gestational diabetes mellitus compared to normal controls. Their negative findings might be due to the differences in timing of maternal blood collection, assay methods used and ethnicity of the study subjects [10] . The discrepancy might also be due to the greater BMI of their study subjects (mean BMI of 30kg/m2 and 28kg/m2 for the GDM and control groups respectively).
The finding of increased maternal inflammatory cytokine (TNF-α) among women with GDM as compared to those with normal gestation, in this study, further supports the previous reports that suggests GDM is associated with amplified inflammatory response.
Conclusion
We conclude that among the pregnant women in this study, those with gestational diabetes mellitus have higher serum TNF-α levels than the pregnant women with normal glucose tolerance regardless of body weight status, suggesting that alterations in the circulating level of TNF-α might be related to the pathogenesis of gestational diabetes mellitus. We recommend larger prospective studies within the population that would examine the mechanism of alteration of the maternal circulating TNF-α level and its pattern from first through third trimester in pregnant women with gestational diabetes mellitus. 
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